141 related articles for article (PubMed ID: 32389047)
1. Survival Differences in Men and Women With Primary Malignant Cardiac Tumor: An Analysis Using the Surveillance, Epidemiology and End Results (SEER) Database From 1973 to 2015.
Antwi-Amoabeng D; Meghji Z; Thakkar S; Ulanja MB; Taha M; Adalja D; Al-Khafaji J; Gullapalli N; Beutler BD; Boampong-Konam K; Doshi R
J Am Heart Assoc; 2020 May; 9(10):e014846. PubMed ID: 32389047
[TBL] [Abstract][Full Text] [Related]
2. Characteristics and Survival of Malignant Cardiac Tumors: A 40-Year Analysis of >500 Patients.
Oliveira GH; Al-Kindi SG; Hoimes C; Park SJ
Circulation; 2015 Dec; 132(25):2395-402. PubMed ID: 26467256
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for early death in primary malignant cardiac tumors: An analysis of over 40 years and 500 patients.
He S; Chen H; Cao Y; Nian F; Xu Y; Chen W; Jiang B; Auchoybur ML; Tao Z; Tang S; Carmichael MJ; Qiu Z; Chen X
Int J Cardiol; 2018 Nov; 270():287-292. PubMed ID: 29960762
[TBL] [Abstract][Full Text] [Related]
4. Characteristics, survival and incidence rates and trends of primary cardiac malignancies in the United States.
Saad AM; Abushouk AI; Al-Husseini MJ; Salahia S; Alrefai A; Afifi AM; Abdel-Daim MM
Cardiovasc Pathol; 2018; 33():27-31. PubMed ID: 29414429
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of primary cardiac malignant tumors: Difference between African American and Caucasian population.
Bui Q; Ngo TNM; Mazur J; Pham V; Palmer C; Truong BQ; Chung ES; Vuong HG; Truong VT
Cancer Med; 2021 Dec; 10(24):8838-8845. PubMed ID: 34761875
[TBL] [Abstract][Full Text] [Related]
6. Survival and analysis of prognostic factors for primary malignant cardiac tumors based on the SEER database.
Chen X; Chen Y; Xiao F; Liu M; Gu Z; Li Y; Hong M
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15687-15696. PubMed ID: 37665405
[TBL] [Abstract][Full Text] [Related]
7. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
[TBL] [Abstract][Full Text] [Related]
8. Age and treatment disparities in survival of primary malignant cardiac tumors: an analysis of over 40 years and 500 patients.
Wang W; Kang L; Zhang J; Li H; Cao T; He S
J Thorac Dis; 2023 Aug; 15(8):4434-4444. PubMed ID: 37691678
[TBL] [Abstract][Full Text] [Related]
9. The incidence and survival outcomes of patients with primary cardiac lymphoma: A SEER-based analysis.
Xiao M; Lin J; Xiao T; Lin Y; Ye Y
Hematol Oncol; 2020 Aug; 38(3):334-343. PubMed ID: 32311106
[TBL] [Abstract][Full Text] [Related]
10. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
11. Geographic variation in malignant cardiac tumors and their outcomes: SEER database analysis.
Rahouma M; Khairallah S; Dabsha A; Baudo M; El-Sayed Ahmed MM; Gambardella I; Lau C; Esmail YM; Mohamed A; Girardi L; Gaudino M; Lorusso R; Mick SL
Front Oncol; 2023; 13():1071770. PubMed ID: 36761976
[TBL] [Abstract][Full Text] [Related]
12. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
13. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
14. Specific causes of death among patients with cardiac sarcoma in the United States-An analysis of The Surveillance, Epidemiology, and End Results (SEER) Program.
Awad AK; Elgenidy A; Afifi AM; Sa MP; Ramlawi B
J Card Surg; 2022 Nov; 37(11):3961-3963. PubMed ID: 35979675
[TBL] [Abstract][Full Text] [Related]
15. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
16. In situ male breast carcinoma in the Surveillance, Epidemiology, and End Results database of the National Cancer Institute.
Anderson WF; Devesa SS
Cancer; 2005 Oct; 104(8):1733-41. PubMed ID: 16138363
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic factors for survival in patients with primary spinal chordoma using the SEER Registry from 1973 to 2014.
Pan Y; Lu L; Chen J; Zhong Y; Dai Z
J Orthop Surg Res; 2018 Apr; 13(1):76. PubMed ID: 29625617
[TBL] [Abstract][Full Text] [Related]
18. Melanoma survival disadvantage in young, non-Hispanic white males compared with females.
Gamba CS; Clarke CA; Keegan TH; Tao L; Swetter SM
JAMA Dermatol; 2013 Aug; 149(8):912-20. PubMed ID: 23804160
[TBL] [Abstract][Full Text] [Related]
19. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
20. Pediatric Malignant Phyllodes Tumors of the Breast: Characteristics and Outcomes Based on the Surveillance Epidemiology and End Results Database.
Xiao Y; Jiang Y; Xiong Y; Ruan S; Huang T
J Surg Res; 2020 May; 249():205-215. PubMed ID: 31991330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
